Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer
- Author
- JONES, S. E; ERBAN, J; MENNEL, R; RICHARDS, D; OLSEN, S; MEYERS, M. L; RAVDIN, P. M; OVERMOYER, B; BUDD, G. T; HUTCHINS, L; LOWER, E; LAUFMAN, L; SUNDARAM, S; URBA, W. J; PNTCHARD, K. I
Hematology Oncology Consultants Inc, Columbus, OH, United States
Providence Portland Medical Center, Portland, OR, United States
Sanofi-Aventis, Bndgewater, NJ, United States
Sharp Rees Steal Medical Group, San Diego, CA, United States
Texas Oncology, Dallas, United States
Toronto Sunnybrook Regional Cancer Center, Toronto, Ontario, Canada
Tufts-New England Medical Center, Boston, MA, United States
University Hospital of Cleveland, and Cleveland Clinic Foundation, Cleveland, United States
University of Arkan sas for Medical Sciences, Little Rock, AR, United States
University of Cincinnati, Cincinnati, United States
University of Texas Health Science Center at San Antonio, San Antonio, TX, United States - Source
Journal of clinical oncology. 2005, Vol 23, Num 24, pp 5542-5551, 10 p ; ref : 43 ref
- ISSN
- 0732-183X
- Scientific domain
- Medical oncology
- Publisher
- Lippincott Williams & Wilkins, Baltimore, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Cancérologie Docétaxel Essai clinique phase III Métastase Paclitaxel Randomisation Stade avancé Traitement Cancer sein Antimitotique Glande mammaire pathologie Taxane dérivé Tumeur maligne
- Keyword (en)
- Antineoplastic agent Cancerology Docetaxel Phase III trial Metastasis Paclitaxel Randomization Advanced stage Treatment Breast cancer Antimitotic Mammary gland diseases Taxane derivatives Malignant tumor
- Keyword (es)
- Anticanceroso Cancerología Docetaxel Ensayo clínico fase III Metástasis Paclitaxel Aleatorización Estadio avanzado Tratamiento Cáncer pecho Antimitótico Glándula mamaria patología Taxane derivado Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20E Mammary gland diseases / 002B20E02 Tumors
- Discipline
- Gynecology. Andrology. Obstetrics Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17166977
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1200/JCO.2005.02.027 
https://dx.doi.org/10.1200/JCO.2005.02.027
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2005.02.027\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"24\";s:8:\"\u0000*\u0000spage\";s:4:\"5542\";s:8:\"\u0000*\u0000epage\";s:4:\"5551\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"JONES\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"ERBAN, J\";i:1;s:9:\"MENNEL, R\";i:2;s:11:\"RICHARDS, D\";i:3;s:8:\"OLSEN, S\";i:4;s:12:\"MEYERS, M. L\";i:5;s:12:\"RAVDIN, P. M\";i:6;s:12:\"OVERMOYER, B\";i:7;s:10:\"BUDD, G. T\";i:8;s:11:\"HUTCHINS, L\";i:9;s:8:\"LOWER, E\";i:10;s:10:\"LAUFMAN, L\";i:11;s:11:\"SUNDARAM, S\";i:12;s:10:\"URBA, W. J\";i:13;s:14:\"PNTCHARD, K. I\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2005.02.027\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"24\";s:8:\"\u0000*\u0000spage\";s:4:\"5542\";s:8:\"\u0000*\u0000epage\";s:4:\"5551\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"JONES\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"ERBAN, J\";i:1;s:9:\"MENNEL, R\";i:2;s:11:\"RICHARDS, D\";i:3;s:8:\"OLSEN, S\";i:4;s:12:\"MEYERS, M. L\";i:5;s:12:\"RAVDIN, P. M\";i:6;s:12:\"OVERMOYER, B\";i:7;s:10:\"BUDD, G. T\";i:8;s:11:\"HUTCHINS, L\";i:9;s:8:\"LOWER, E\";i:10;s:10:\"LAUFMAN, L\";i:11;s:11:\"SUNDARAM, S\";i:12;s:10:\"URBA, W. J\";i:13;s:14:\"PNTCHARD, K. I\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2005.02.027\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2005.02.027\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"24\";s:8:\"\u0000*\u0000spage\";s:4:\"5542\";s:8:\"\u0000*\u0000epage\";s:4:\"5551\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"JONES\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"ERBAN, J\";i:1;s:9:\"MENNEL, R\";i:2;s:11:\"RICHARDS, D\";i:3;s:8:\"OLSEN, S\";i:4;s:12:\"MEYERS, M. L\";i:5;s:12:\"RAVDIN, P. M\";i:6;s:12:\"OVERMOYER, B\";i:7;s:10:\"BUDD, G. T\";i:8;s:11:\"HUTCHINS, L\";i:9;s:8:\"LOWER, E\";i:10;s:10:\"LAUFMAN, L\";i:11;s:11:\"SUNDARAM, S\";i:12;s:10:\"URBA, W. J\";i:13;s:14:\"PNTCHARD, K. I\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2005.02.027\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"24\";s:8:\"\u0000*\u0000spage\";s:4:\"5542\";s:8:\"\u0000*\u0000epage\";s:4:\"5551\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"JONES\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"ERBAN, J\";i:1;s:9:\"MENNEL, R\";i:2;s:11:\"RICHARDS, D\";i:3;s:8:\"OLSEN, S\";i:4;s:12:\"MEYERS, M. L\";i:5;s:12:\"RAVDIN, P. M\";i:6;s:12:\"OVERMOYER, B\";i:7;s:10:\"BUDD, G. T\";i:8;s:11:\"HUTCHINS, L\";i:9;s:8:\"LOWER, E\";i:10;s:10:\"LAUFMAN, L\";i:11;s:11:\"SUNDARAM, S\";i:12;s:10:\"URBA, W. J\";i:13;s:14:\"PNTCHARD, K. I\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2005.02.027\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"24\";s:8:\"\u0000*\u0000spage\";s:4:\"5542\";s:8:\"\u0000*\u0000epage\";s:4:\"5551\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"JONES\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"ERBAN, J\";i:1;s:9:\"MENNEL, R\";i:2;s:11:\"RICHARDS, D\";i:3;s:8:\"OLSEN, S\";i:4;s:12:\"MEYERS, M. L\";i:5;s:12:\"RAVDIN, P. M\";i:6;s:12:\"OVERMOYER, B\";i:7;s:10:\"BUDD, G. T\";i:8;s:11:\"HUTCHINS, L\";i:9;s:8:\"LOWER, E\";i:10;s:10:\"LAUFMAN, L\";i:11;s:11:\"SUNDARAM, S\";i:12;s:10:\"URBA, W. J\";i:13;s:14:\"PNTCHARD, K. I\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
